Hamdan Bin Rashid Al Maktoum Foundation for Medical and Educational Sciences participated in the second edition of the Dubai Medical Research Forum (DMRF 2025), organized by Dubai Health Authority on September 12–13 at the Grand Hyatt Dubai. The event brought together leading researchers, healthcare executives, and policymakers from the UAE and abroad.
At its dedicated pavilion within the accompanying exhibition, the Foundation showcased key medical initiatives and community-focused research programs, with particular emphasis on its medical awards, studies, and scientific contributions. Dr. Salama Al Muhairi, Director of Medical Excellence at Hamdan Bin Rashid Al Maktoum Foundation, also joined a panel discussion where she highlighted the Foundation’s efforts to promote excellence in medical education and research, underscoring initiatives designed to foster an innovative knowledge environment that enhances the quality of educational and healthcare services.
Commenting on the occasion, Dr. Salama Al Muhairi, Director of the Medical Excellence Department at Hamdan Bin Rashid Al Maktoum Foundation for Medical and Educational Sciences, said: “This forum represents a vital strategic platform to showcase best practices, address shared challenges, and activate research partnerships among leading institutions regionally and internationally. At the Foundation, we believe that excellence in healthcare begins with a deep understanding of community needs and is realized through research that shapes flexible, world-class health policies. Our participation this year reaffirms our commitment to strengthening a culture of continuous learning and expanding collaboration with decision-makers, academics, and researchers in pursuit of a healthcare system that is more efficient, equitable, and innovative.”
The forum reflects growing momentum toward building a modern, integrated research ecosystem founded on ethical standards and smart regulations, aligned with the UAE’s vision to lead the healthcare sector regionally and globally. High-level discussions are expected to focus on patient-centered innovation, research governance, and stronger integration between healthcare institutions, universities, and scientific centers.
